10x Genomics, Inc.TXGNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-1.95%
↑ 95% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-39.89%
Historical baseline
PeriodValueYoY Change
TTM-1.95%+91.1%
2024-21.94%+33.8%
2023-33.15%-33.2%
2022-24.88%-396.2%
2021-5.01%+97.1%
2020-171.92%-1923.8%
2019-8.49%+88.3%
2018-72.50%-278.3%
2017-19.17%-